Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical tria…
Biotechnology
US, Bala Cynwyd [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Larimar Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Larimar Therapeutics, Inc. has no acquisition track records yet.